Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.69% |
| 2 | Technology | 12.68% |
| 3 | Financials | 12.18% |
| 4 | Consumer Discretionary | 10.77% |
| 5 | Industrials | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
United Therapeutics
UTHR
$25.9B
| $3.97M | 0.01% |
36,463
-94,789
| -72% | -$11M |
|
1727
CALL
Booking.com
BKNG
$156B
| $3.96M | 0.01% |
57,500
+47,500
| +475% | +$3.48M |
|
1728
CALL
Charles River Laboratories
CRL
$11.4B
| $3.96M | 0.01% |
+35,000
| New | +$4.38M |
|
|
MDRX
1729
DELISTED
Veradigm Inc. Common Stock
MDRX
| $3.96M | 0.01% |
410,921
-1,640,783
| -80% | -$18.3M |
|
1730
Valvoline
VVV
$5.05B
| $3.95M | 0.01% |
203,947
+50,348
| +33% | +$1.01M |
|
1731
Photronics
PLAB
$1.65B
| $3.94M | 0.01% |
407,337
-551,271
| -58% | -$5.3M |
|
|
PETX
1732
DELISTED
Aratana Therapeutics, Inc.
PETX
| $3.94M | 0.01% |
642,923
+346,243
| +117% | +$2.11M |
|
1733
Kulicke & Soffa
KLIC
$4.34B
| $3.93M | 0.01% |
193,754
-305,821
| -61% | -$6.34M |
|
|
CHMI
1734
Cherry Hill Mortgage Investment Corp
CHMI
$81.9M
| $3.92M | 0.01% |
223,336
+39,682
| +22% | +$725K |
|
1735
TIM SA
TIMB
$9.24B
| $3.92M | 0.01% |
255,284
-271,658
| -52% | -$4.17M |
|
1736
Cogent Communications
CCOI
$597M
| $3.9M | 0.01% |
+86,324
| New | +$4.27M |
|
1737
PUT
Analog Devices
ADI
$173B
| $3.9M | 0.01% |
45,400
+24,800
| +120% | +$2.15M |
|
1738
Linde
LIN
$236B
| $3.89M | 0.01% |
+24,949
| New | +$3.94M |
|
|
MFA
1739
MFA Financial
MFA
$936M
| $3.89M | 0.01% |
145,654
-1,717,314
| -92% | -$48.2M |
|
1740
OFG Bancorp
OFG
$2.22B
| $3.89M | 0.01% |
236,283
+164,182
| +228% | +$2.76M |
|
1741
Telecom Argentina
TEO
$5.85B
| $3.88M | 0.01% |
249,304
+112,380
| +82% | +$1.93M |
|
|
DOCU
1742
DocuSign
DOCU
$11.1B
| $3.88M | 0.01% |
+96,713
| New | +$4.06M |
|
|
QIWI
1743
DELISTED
QIWI PLC
QIWI
| $3.87M | 0.01% |
273,559
+183,251
| +203% | +$2.47M |
|
|
DERM
1744
DELISTED
Dermira, Inc.
DERM
| $3.85M | 0.01% |
535,707
-1,841,674
| -77% | -$20.1M |
|
1745
Voyager Therapeutics
VYGR
$182M
| $3.85M | 0.01% |
409,270
-58,346
| -12% | -$749K |
|
|
RFP
1746
DELISTED
Resolute Forest Products Inc.
RFP
| $3.85M | 0.01% |
485,028
-383,576
| -44% | -$4.23M |
|
1747
PUT
eHealth
EHTH
$42.2M
| $3.84M | 0.01% |
+100,000
| New | +$3.36M |
|
|
ATTU
1748
DELISTED
Attunity Ltd
ATTU
| $3.83M | 0.01% |
194,729
-85,981
| -31% | -$1.63M |
|
1749
PUT
Intuitive Surgical
ISRG
$127B
| $3.83M | 0.01% |
+24,000
| New | +$4.07M |
|
1750
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
| $3.83M | 0.01% |
49,116
-3,627
| -7% | -$282K |
|
Similar funds
Millennium Management's Q4 2018 Portfolio in Review
As of Q4 2018, Millennium Management held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Millennium Management withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Millennium Management opened a new position in Athenahealth, Inc. worth $135M.
- Millennium Management's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Millennium Management added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Millennium Management's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Millennium Management fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Millennium Management's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Millennium Management opened 702 new positions and closed 844 in Q4 2018.
- Millennium Management's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.